This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuchs, P. C.
Right arrow Articles by Brown, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuchs, P. C.
Right arrow Articles by Brown, S. D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2002, p. 398-401, Vol. 46, No. 2
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.2.398-401.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Selection of Zone Size Interpretive Criteria for Disk Diffusion Susceptibility Tests of Three Antibiotics against Streptococcus pneumoniae, Using the New Guidelines of the National Committee for Clinical Laboratory Standards

Peter C. Fuchs,* Arthur L. Barry, and Steven D. Brown

The Clinical Microbiology Institute, Wilsonville, Oregon 97070

Received 13 August 2001/ Returned for modification 3 October 2001/ Accepted 6 November 2001

Disk diffusion and broth microdilution susceptibility tests were performed with cefotaxime, ceftriaxone, telithromycin, and erythromycin (control) against 407 selected isolates of Streptococcus pneumoniae. Scattergrams were prepared from the results of these tests, and the current NCCLS guidelines for setting disk diffusion test interpretive criteria were applied. Erythromycin zone diameter breakpoints were confirmed. Telithromycin interpretive criteria for the disk test could be easily set with acceptable discrepancy rates. For cefotaxime and ceftriaxone, the minor discrepancy rates for MICs in the intermediate category ± 1 dilution were far in excess of the acceptable 40% limit, i.e., 52 and 71%, respectively. We conclude that the 30-µg disk of these two drugs cannot be reliably used to test pneumococci.

* Corresponding author. Mailing address: The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, OR 97070. Phone: (503) 682-3232. Fax: (503) 682-2065. E-mail: cmi{at}hevanet.com..

Antimicrobial Agents and Chemotherapy, February 2002, p. 398-401, Vol. 46, No. 2
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.2.398-401.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Mayrhofer, S., Domig, K. J., Mair, C., Zitz, U., Huys, G., Kneifel, W. (2008). Comparison of Broth Microdilution, Etest, and Agar Disk Diffusion Methods for Antimicrobial Susceptibility Testing of Lactobacillus acidophilus Group Members. Appl. Environ. Microbiol. 74: 3745-3748 [Abstract] [Full Text]  
  • Reinert, R. R., Lutticken, R., Sutcliffe, J. A., Tait-Kamradt, A., Cil, M. Y., Schorn, H. M., Bryskier, A., Al-Lahham, A. (2004). Clonal Relatedness of Erythromycin-Resistant Streptococcus pyogenes Isolates in Germany. Antimicrob. Agents Chemother. 48: 1369-1373 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»